Fri Jan 03 13:40:00 UTC 2025: **Quantum-Si Stock Soars 40% on Increased Trading Volume and Analyst Upgrade**

**Sioux Falls, SD –** Quantum-Si Incorporated (NASDAQ: QSI), a life sciences company specializing in next-generation protein sequencing, experienced a significant surge in its stock price on Thursday, closing at $3.77, a 39.6% increase from the previous day’s close of $2.70. Trading volume skyrocketed to 67,820,135 shares, a 1,205% increase over the average daily volume.

The dramatic price jump follows a positive analyst report from HC Wainwright, which raised its price target for QSI stock from $4.00 to $5.50 and maintained a “buy” rating. This upgrade countered a previous downgrade from Canaccord Genuity Group, which lowered its price target to $1.00 and issued a “hold” rating.

Adding to the market activity, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock on December 27th at an average price of $3.34, representing a 73.72% decrease in his holdings. Despite this insider sale, institutional investor interest remains high, with several firms increasing their stakes in QSI during recent quarters. These include Bank of New York Mellon Corp, XTX Topco Ltd, SG Americas Securities LLC, Green Alpha Advisors LLC, and Barclays PLC. Insiders collectively own 30.04% of the company’s stock, and institutional investors own 39.90%.

Quantum-Si develops a single-molecule detection platform for next-generation protein sequencing (NGPS), comprising the Platinum NGPS instrument, Platinum Analysis Software, and related reagents and semiconductor chips. The company has a market cap of $607.96 million, a P/E ratio of -6.66, and a beta of 3.20. Despite the recent surge, MarketBeat notes that QSI was not included in its list of top-rated stocks recommended by leading analysts.

Read More